# COBIT-Chain™ Strategic AI Partnership Assurance R1

**Status:** `ROADMAP_ONLY / ARCHITECTURE_ASSIMILATION`  
**Repository record:** 18 August 2026 UTC  
**Implementation effect:** documentation/roadmap only  
**Canonical Audit R3 effect:** none

## 1. Purpose

Strategic AI providers can move beyond ordinary vendor status and become shared scientific infrastructure across discovery, preclinical, clinical, regulatory, manufacturing, quality, and enterprise knowledge workflows. That creates assurance questions that are not fully represented by ordinary supplier qualification alone.

This addendum extends existing COBIT-Chain capability families without creating a duplicate sovereign engine.

`STRATEGIC_AI_PARTNERSHIP_ASSURANCE = COMPOSITE_PROFILE`

`COMPOSITE_PROFILE != NEW_AUTHORITY_ENGINE`

`ROADMAP_RECORDED != IMPLEMENTED`

## 2. Existing anchors preserved

The capabilities below must compose or extend existing COBIT-Chain families, including where applicable:

- Supplier / Procurement / Sole-Source Dependency Graph
- Supplier Change Notification Standing
- AI Supplier Evidence Passport
- Source / Version Provenance
- Intended-Use Drift and re-evaluation
- Probabilistic Validation Standing
- Validation Standing Assurance
- Authority Delegation / Currency / Expiry / Revocation
- No-Bind Governance
- Change Consequence Assurance
- Recovery / Return-to-Service Assurance
- Cross-System Closure / Re-closure
- SERAPH Evidence Integrity
- ARCHANGEL assurance-ledger roadmap

Duplicate capability creation is prohibited where an existing engine can supply the required primitive.

## 3. Capability 57 — Strategic AI Dependency Concentration & Correlated Exposure Graph

### Assurance question

How much regulated or scientific reliance has accumulated around one AI provider, model family, hosted service, foundation model, or common technical dependency, and which consequences could fail together if that dependency changes or becomes unavailable?

### Future governed objects

- provider and contractual entity
- model family / base model / hosted service
- versions and effective dates
- relying business processes
- relying GxP/scientific intended uses
- sites, functions, programs, studies, products, and pipelines affected
- shared upstream dependencies
- business-continuity and substitution dependencies
- concentration indicators
- correlated-failure domains
- criticality and SISPQ consequence links where applicable

### Required doctrine

`MULTIPLE_APPROVED_USES != INDEPENDENT_FAILURE_DOMAINS`

`SUPPLIER_APPROVED != CONCENTRATION_RISK_ACCEPTABLE`

A provider can remain qualified while concentration risk becomes unacceptable or requires additional resilience controls.

## 4. Capability 58 — Cross-Partner Data / Model Improvement Spillover Assurance

### Assurance question

When the same AI provider or model family serves multiple organizations, what evidence establishes that one party's proprietary or regulated data, feedback, fine-tuning, retrieval corpus, derived features, or model improvements cannot inappropriately influence another party's environment?

### Future governed evidence

- data-use and training-use restrictions
- tenant / workspace / project isolation evidence
- base-model and adaptation lineage
- fine-tune / adapter / retrieval-corpus identity
- model-improvement opt-in/opt-out state
- cross-customer data-flow controls
- provider attestations and contractual controls
- technical isolation verification where available
- exceptions, incidents, and remediation evidence
- change events that alter the isolation basis

### Required doctrine

`TENANT_LABEL != PROVEN_DATA_ISOLATION`

`NO_TRAINING_CLAIM != COMPLETE_SPILLOVER_ASSURANCE`

The assurance object is the bounded evidence supporting separation for the specific data, model path, purpose, and time window.

## 5. Capability 59 — Joint-IP & Derived-Model Rights Provenance Ledger

### Assurance question

What evidence establishes the ownership, license, permitted use, transferability, and downstream reliance rights for AI-assisted scientific assets and model-derived outputs at the moment they are used?

### Future provenance chain

- source datasets and rights
- provider pre-existing IP
- sponsor pre-existing IP
- jointly generated training/fine-tuning assets
- model / adapter / prompt / tool versions
- AI-generated candidate or scientific output
- human scientific modification
- experimental confirmation and derived datasets
- contractual ownership and license clauses
- territorial / field-of-use restrictions
- publication / regulatory-submission rights
- downstream manufacturing or commercialization rights
- supersession and amendment history

### Required doctrine

`TECHNICAL_PROVENANCE != LEGAL_RIGHT_TO_USE`

`OUTPUT_CREATED != OUTPUT_RIGHTS_ESTABLISHED`

The ledger must preserve both technical lineage and the evidence of the rights relied upon; it must not infer legal ownership from technical creation alone.

## 6. Capability 60 — Supplier Exit, Portability & Substitution Standing

### Assurance question

If a strategic AI dependency becomes unavailable, materially changes, is terminated, or must be replaced, can the organization reproduce, migrate, substitute, or retire the dependency without silently inheriting standing from the prior supplier or model?

### Future governed route

`DEPENDENCY_LOSS_OR_CHANGE`
→ impact analysis
→ affected intended uses identified
→ required evidence/export package assessed
→ alternative supplier/model/service identified
→ portability and reproducibility assessed
→ equivalence / non-equivalence determined
→ validation / qualification / security / data-rights review
→ accountable approval where required
→ standing re-established for the replacement
→ controlled migration
→ old dependency formally closed / revoked
→ recovery and re-closure evidence preserved

### Required doctrine

`CURRENT_STANDING != SUBSTITUTION_READINESS`

`REPLACEMENT_AVAILABLE != REPLACEMENT_HAS_STANDING`

`SUPPLIER_EXIT != AUTOMATIC_STANDING_TRANSFER`

## 7. Capability 61 — AI Influence-to-Scientific-Decision Attribution Chain

### Assurance question

When AI does not execute the final regulated action but materially shapes a scientist's or accountable reviewer's judgment, can that influence be reconstructed without transferring accountable authority to the AI?

### Future attribution chain

- AI observation / recommendation / generated hypothesis
- model, prompt, tool, retrieval, and source context
- supporting evidence and uncertainty
- limitations / dissenting evidence
- human reviewer identity and role
- accepted, rejected, and modified AI elements
- independent human rationale where required
- accountable scientific or quality decision
- downstream consequence / study / experiment / submission / process impact
- later evidence that changes the basis for the decision

### Required doctrine

`AI_INFLUENCE != ACCOUNTABLE_AUTHORITY`

`HUMAN_CLICKED_APPROVE != HUMAN_REVIEW_EFFECTIVE`

`FINAL_HUMAN_DECISION != AI_INFLUENCE_ABSENT`

The architecture should preserve AI influence as evidentially significant while maintaining the human-authority and No-Bind boundaries.

## 8. Composite Strategic AI Partnership Assurance profile

A future profile may compose capabilities 57–61 with existing supplier, provenance, validation-standing, authority, change, recovery, evidence-integrity, and re-closure engines.

The profile should be able to answer, without creating a separate authority model:

1. How concentrated is reliance on this provider/model family?
2. Are data and model-improvement boundaries still supportable?
3. Are IP and derived-asset rights traceable for the intended use?
4. Can the dependency be exited or substituted without losing the evidentiary basis for standing?
5. How did AI influence the accountable scientific decision?
6. What supplier/model/data change requires re-evaluation now?

## 9. Non-erasure learning rule

A bounded finding that leads to stronger engineering must remain part of the governed chronology.

`EARLIER_GAP + LATER_REPAIR != EARLIER_GAP_NEVER_EXISTED`

Future assurance evidence should link:

`EVIDENCE → BOUNDED_FINDING → ENGINEERING_RESPONSE → NEW_EVIDENCE → RE-EVALUATION`

This rule strengthens institutional learning while preserving historical truth and prevents later improvements from rewriting the evidence boundary that existed when the original determination was made.

## 10. Maturity and authorization boundary

All five capabilities are `ROADMAP_ONLY` in this R1 document.

This record does **not**:

- implement a runtime evaluator;
- modify any frozen Canonical Audit R3 artifact;
- authorize R3-E06;
- authorize autonomous release or approval;
- create a new binding authority engine;
- change RAMAT Vision's witness-only boundary;
- authorize Azure, hardware, firmware, sensor, camera, Jetson, or production-system activity;
- claim GxP validation, regulatory acceptance, legal determination, or production readiness.

Future implementation requires separately governed scope, current-repository reconciliation, schemas, challenge cases, verification evidence, and explicit authorization.
